Advertisement

Hepatitis B Vaccination Among Adults With Diabetes Mellitus, U.S., 2018

      Introduction

      Hepatitis B vaccination is routinely recommended for adults with diabetes mellitus aged <60 years and for those aged ≥60 years at the discretion of their healthcare provider. The purpose of this study is to assess hepatitis B vaccination coverage among adults with and without diabetes mellitus.

      Methods

      Data from the 2014–2018 National Health Interview Survey were analyzed in 2020 to determine hepatitis B vaccination series completion (≥3 doses) among adults aged 18–59 and ≥60 years with diabetes mellitus. Multivariable logistic regression analysis was conducted to identify the factors independently associated with hepatitis B vaccination among adults aged 18–59 and ≥60 years with diabetes mellitus.

      Results

      In 2018, among adults aged 18–59 years with diabetes mellitus, 33.2% had received hepatitis B vaccination (≥3 doses), an increase of 9.7 percentage points from 2014 (p<0.05). Among adults aged ≥60 years with diabetes mellitus, coverage was 15.3% in 2018 and did not increase during 2014–2018. Coverage was not significantly different among adults with diabetes mellitus compared with those without diabetes mellitus, even after controlling for the assessed factors. Among adults with diabetes mellitus aged 18–59 and ≥60 years, younger age, having some college or college education, having been tested for HIV, being healthcare personnel, or having traveled to hepatitis B virus–endemic areas were independently associated with an increased likelihood of vaccination.

      Conclusions

      Self-reported hepatitis B vaccination coverage among adults with diabetes mellitus remains suboptimal. Healthcare providers should assess patients’ diabetes status, recommend and offer needed vaccinations to patients, or refer them to alternate sites for vaccination.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Centers for Disease Control and Prevention (CDC)
        Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2011; 60: 1709-1711
        • Schillie S
        • Vellozzi C
        • Reingold A
        • et al.
        Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.
        MMWR Recomm Rep. 2018; 67: 1-31https://doi.org/10.15585/mmwr.rr6701a1
        • Reilly ML
        • Schillie SF
        • Smith E
        • et al.
        Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus.
        J Diabetes Sci Technol. 2012; 6: 858-866https://doi.org/10.1177/193229681200600417
      1. Centers for Disease Control and Prevention, Health care-associated hepatitis B and C outbreaks (≥2 cases) reported to the CDC 2008–2019.
        Centers for Disease Control and Prevention, 2020 (Updated May 11,)
        • Villarroel MA
        • Vahratian A.
        Vaccination coverage among adults with diagnosed diabetes: United States, 2015.
        NCHS Data Brief. 2016; : 1-8
        • Byrd KK
        • Lu PJ
        • Murphy TV.
        Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination.
        Vaccine. 2012; 30: 3376-3382https://doi.org/10.1016/j.vaccine.2012.03.055
        • National Health Interview Survey
        Centers for Disease Control and Prevention.
        2020 (Updated October 20,)
        • Shah B
        • Barnwell B
        • Bieier G.
        SUDAAN User's Manual, Release 11.1.
        Research Triangle Institute, Research Triangle Park, NC2010
        • National Academies of Sciences, Engineering, and Medicine
        A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report.
        The National Academies Press, Washington, DC2017https://doi.org/10.17226/24731
        • Egede LE
        • Zheng D.
        Racial/ethnic differences in influenza vaccination coverage in high-risk adults.
        Am J Public Health. 2003; 93: 2074-2078https://doi.org/10.2105/ajph.93.12.2074
        • Singleton JA
        • Wortley PM
        • Lu PJ.
        Influenza vaccination of persons with cardiovascular disease in the United States.
        Tex Heart Inst J. 2004; 31: 22-27
        • Nichol KL
        • Zimmerman R.
        Generalist and subspecialist physicians’ knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey.
        Arch Intern Med. 2001; 161: 2702-2708https://doi.org/10.1001/archinte.161.22.2702
        • Bridges CB
        • Hurley LP
        • Williams WW
        • Ramakrishnan A
        • Dean AK
        • Groom AV.
        Meeting the challenges of immunizing adults.
        Am J Prev Med. 2015; 49: S455-S464https://doi.org/10.1016/j.amepre.2015.08.014
        • Joon Lee TJ
        • Hayes S
        • Cummings DM
        • et al.
        Herpes zoster knowledge, prevalence, and vaccination rate by race.
        J Am Board Fam Med. 2013; 26: 45-51https://doi.org/10.3122/jabfm.2013.01.120154
        • Johnson DR
        • Nichol KL
        • Lipczynski K.
        Barriers to adult immunization.
        Am J Med. 2008; 121: S28-S35https://doi.org/10.1016/j.amjmed.2008.05.005
        • Winston CA
        • Wortley PM
        • Lees KA.
        Factors associated with vaccination of Medicare beneficiaries in five U.S. communities: results from the Racial and Ethnic Adult Disparities in Immunization Initiative survey, 2003.
        J Am Geriatr Soc. 2006; 54: 303-310https://doi.org/10.1111/j.1532-5415.2005.00585.x
        • Hurley LP
        • Bridges CB
        • Harpaz R
        • et al.
        U.S. physicians’ perspective of adult vaccine delivery.
        Ann Intern Med. 2014; 160: 161https://doi.org/10.7326/M13-2332
        • Strikas RA.
        The power to protect: vaccination guidelines for adults with chronic diseases.
        Medscape, New York, NY2017 (Published October 2,)
      2. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).
        MMWR Recomm Rep. 1991; 40: 1-25
        • Centers for Disease Control and Prevention (CDC)
        Update: recommendations to prevent hepatitis B virus transmission–United States.
        MMWR Morb Mortal Wkly Rep. 1995; 44: 574-575
        • Hill HA
        • Singleton JA
        • Yankey D
        • Elam-Evans LD
        • Pingali SC
        • Kang Y.
        Vaccination coverage by age 24 months among children born in 2015 and 2016—national Immunization Survey-Child, United States, 2016-2018.
        MMWR Morb Mortal Wkly Rep. 2019; 68: 913-918https://doi.org/10.15585/mmwr.mm6841e2
        • Walker TY
        • Elam-Evans LD
        • Yankey D
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years - United States, 2018.
        MMWR Morb Mortal Wkly Rep. 2019; 68: 718-723https://doi.org/10.15585/mmwr.mm6833a2
        • Elam-Evans LD
        • Yankey D
        • Singleton JA
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years - United States, 2019.
        MMWR Morb Mortal Wkly Rep. 2020; 69: 1109-1116https://doi.org/10.15585/mmwr.mm6933a1
        • Lu PJ
        • Byrd KK
        • Murphy TV.
        Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.
        Vaccine. 2013; 31: 2348-2357https://doi.org/10.1016/j.vaccine.2013.03.011
        • Daniels D
        • Grytdal S
        • Wasley A
        • Centers for Disease Control and Prevention (CDC)
        Surveillance for acute viral hepatitis–United States, 2007.
        MMWR Surveill Summ. 2009; 58: 1-27
      3. Centers for Disease Control and Prevention. Surveillance for viral hepatitis – United States, 2017. https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm. Updated November 14, 2019. Accessed January 27, 2021.

        • Lu PJ
        • Byrd KK
        • Murphy TV
        • Weinbaum C.
        Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
        Vaccine. 2011; 29: 7049-7057https://doi.org/10.1016/j.vaccine.2011.07.030
        • Centers for Disease Control and Prevention (CDC)
        Update: recommendations to prevent hepatitis B virus transmission–United States.
        MMWR Morb Mortal Wkly Rep. 1999; 48: 33-34
        • Mast EE
        • Weinbaum CM
        • Fiore AE
        • et al.
        A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults [published correction appears in MMWR Morb Mortal Wkly Rep. 2007;56(42):1114].
        MMWR Recomm Rep. 2006; 55 (1–CE4)
        • Trevisan A
        • Frasson C
        • Morandin M
        • et al.
        Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease.
        Infect Control Hosp Epidemiol. 2007; 28: 564-569https://doi.org/10.1086/516657
        • Stange KC
        • Zyzanski SJ
        • Smith TF
        • et al.
        How valid are medical records and patient questionnaires for physician profiling and health services research? A comparison with direct observation of patients visits.
        Med Care. 1998; 36: 851-867https://doi.org/10.1097/00005650-199806000-00009
        • Rolnick SJ
        • Parker ED
        • Nordin JD
        • et al.
        Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?.
        Vaccine. 2013; 31: 3928-3935https://doi.org/10.1016/j.vaccine.2013.06.041
        • Centers for Disease Control and Prevention
        National diabetes statistics report 2020: estimates of diabetes and its burden in the United States.
        Centers for Disease Control and Prevention, HHS, Atlanta, GA2020 (Published)
        • Silver A
        • Figge J
        • Haskin DL
        • et al.
        An asthma and diabetes quality improvement project: enhancing care in clinics and community health centers [published correction appears in J Community Health. 2011;36(2):191–192].
        J Community Health. 2011; 36: 180-190https://doi.org/10.1007/s10900-010-9296-8
        • McLaughlin S.
        The diabetes quality improvement project.
        Diabetes Spectr. 2000; 13: 5-10
      4. American Association of Diabetes Educators. Vaccination practice for people with diabetes.
        American Association of Diabetes Educators, Chicago, IL2019 (Published)
      5. National Vaccine Advisory Committee. Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice.
        Public Health Rep. 2014; 129: 115-123https://doi.org/10.1177/003335491412900203
      6. Increasing appropriate vaccination: health care system-based interventions implemented in combination (2010 archived review).
        Community Preventive Services Task Force, 2015 (Updated June 5,)